|
Market Cap (17-May) $40,671,720 (1,053rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 400,697 |
Shortsold (10-Dec) 1,128,575 (0.62%) (255th) |
|
52w High $0.345 |
52w Low $0.140 |
P/E - |
EPS -0.05 |
CYP released this announcement to the ASX on 6 February 2023, 17:44. The announcement is not marked as price sensitive, and is 4 page(s) in length and 21.68kb in size.
You can view all announcements from CYP and see how they appear on a price chart on the announcements page.
At the date of this announcement, CYP was 0.003% short sold according to ASIC data. It was ranked the 613th most shorted stock on the ASX. It is now ranked as the 255th most shorted stock on the ASX with 0.624% of total shares short sold as of the latest reported data (10 December 2024).
| Other Recent Announcements from CYP | |
|---|---|
| Notification regarding unquoted securities - CYP | 30 June 2023, 13:10 |
| Proposed issue of securities - CYP | 30 June 2023, 9:44 |
| Cynata announces CEO succession and Board changes | 30 June 2023, 9:13 |
| Notification of cessation of securities - CYP | 6 February 2023, 17:44 |
| Quarterly Activity Report & Appendix 4C | 31 January 2023, 13:27 |
| Cynata Receives IRB Approval for aGvHD Clinical Trial | 30 January 2023, 9:06 |
| Notice of Acceptance for Cynata Australian Patent | 9 January 2023, 12:41 |
You must be logged in to post a reply.
Cynata Therapeutics 